In order to study the potential implication of the AHR signaling the more primitive CML stem cells; we have performed a bioinformatics analysis of the gene profiling data of CML CD34+CD38-cells. The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.